Top Small Cap Gainers: SNSE, GTH, SKYT
3:16 pm Thursday, May 20th, 2021
Sensei Biotherapeutics Inc (NASDAQ:SNSE) stock soars 31% to $12.73 after the company announced new data from its ongoing Phase 1/2 trial of SNS-301 in patients with advanced squamous cell carcinoma of the head and neck in combination with pembrolizumab. Among efficacy data, in an analysis of anti-tumor activity conducted in 12 patients in Cohort A, 8 of 12 patients achieved stable disease or partial response, including one patient with PD-L1 negative tumor who achieved a tumor reduction of 71% that is still ongoing after 11 months of therapy.
Genetron Holdings Ltd (NASDAQ:GTH) surged 18% to $22.87 after the company announced a strategic partnership with JD.com (JD) subsidiary JD Health to create solutions for full-cycle cancer management. The partnership will focus on consumer healthcare and digitization of liver disease management, among other key areas; the first phase of the partnership will focus on liver and lung cancer.
Skywater Technology Inc (NASDAQ:SKYT) stock has moved up 22.15% as the April IPO rises to new highs. Among recent press, community chip creation platform Efabless today launched its chipIgnite platform and a collaboration with co; co’s open source SKY130 process is the first node to be used to fabricate chips for the program.
